Evidence map›Paper›PMID 33062966›Full record

ArticleEuropean journal of breast health2020

Colour Coding Navigation: "Triage" Techniques to Improve Compliance in Breast Cancer Patients Requiring Primary Chemotherapy.

Carol Ann Benn, Yastira Ramdas, Barend van den Bergh, Naa-Lamle Bannerman, Dominic van Loggerenberg, Tia van Loggerenberg, Vernon Shaw

Open access · diamondAbstract read
In one paragraph

Article in European journal of breast health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Carol Ann BennNetcare Breastcare Centre of Excellence, Milpark Hospital, Johannesburg, South Africa.ORCID 0000-0002-4777-4316
Yastira RamdasNetcare Breastcare Centre of Excellence, Milpark Hospital, Johannesburg, South Africa.ORCID 0000-0001-6109-0140
Barend van den BerghNetcare Breastcare Centre of Excellence, Milpark Hospital, Johannesburg, South Africa.ORCID 0000-0002-0571-9140
Naa-Lamle BannermanNetcare Breastcare Centre of Excellence, Milpark Hospital, Johannesburg, South Africa.ORCID 0000-0001-7204-4799
Dominic van LoggerenbergNetcare Breastcare Centre of Excellence, Milpark Hospital, Johannesburg, South Africa.ORCID https://orcid.org/0000-0002-5130-5651
Tia van LoggerenbergNetcare Breastcare Centre of Excellence, Milpark Hospital, Johannesburg, South Africa.ORCID 0000-0002-9420-9627
Vernon ShawNetcare Breastcare Centre of Excellence, Milpark Hospital, Johannesburg, South Africa.ORCID 0000-0003-4557-3921
Netcare Unitas Hospital · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis is a pilot study to assess whether a file-colour-coded triage navigation system for patients on primary chemotherapy improves compliance and adherence and if it decreases defaulting. MATERIALS AND

methodsAll breast cancer patients are discussed in a multidisciplinary meeting. All patients are triaged before starting on primary chemotherapy based on their specific challenges and beliefs and are consulted by the navigation team and contacted before the beginning of treatment and after each chemotherapy session by a navigator in the unit. File stratification for ease of navigation was instituted by a colour code dot into three groups. The three groups are:Code Green: Compliant on treatmentCode Yellow: Side effects on treatment/ considering defaultingCode Red: Non-compliantThe code red patients were further assessed in terms of reasons for non-adherence or non-compliance:Fear of chemotherapy side effectsThe belief that chemotherapy kills the patientInterest in "alternative treatment regimens"Other barriers to treatment as identified by the navigators.

resultsThe system allows the navigation team to focus on which patients require specific navigation and inform the treating oncologists. Code green patients were courtesy called after each chemotherapy session. The code yellow patients had early involvement with the survivorship team to ensure appropriate management of any side effects. Access to the complimentary oncology navigator and complementary health website was instituted. The oncology navigator visited each patient at the oncology unit on the day the patient was due to have chemotherapy. For Code red 1 and 2, a "buddies" network of patients who have been through similar treatment regimens was assigned by the navigation team. This was coordinated by patient navigators (trained counsellors who have had breast cancer treatment). Code red three was managed by a complementary health specialist who understood the value of chemotherapy. For Code red 4, the oncology navigator manages the concerns from finances services to family issues. For the 122 patients in total for primary chemotherapy, stratification was as follows:Code Green=64.8%Code Yellow=27.0%Code Red=8.2%.

conclusionThis system provides the Multidisciplinary team with the opportunity to improve patient adherence/compliance with primary chemotherapy. 80% of the code red patients eventually agreed to receive the recommended treatment. Navigation enhanced patient supervision, and the coding system improved patient primary chemotherapy adherence. Such a system would benefit larger oncological practices to improve primary chemotherapy adherence by empowering the navigation team to identify patients requiring more intensive navigation supervision.

Indexed as

Breast cancernavigationneoadjuvant chemotherapypatient adherencepatient compliance

Identifiers

PMID33062966
PMCPMC7535990
OpenAlexW3088512847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.